|
ZymoGenetics, Inc. - Company Profile Snapshot
| Company Profile: |
ZymoGenetics, Inc. |
| Ticker: |
ZGEN |
| Exchanges: |
NAS |
| 2008 Sales: |
73,989,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Ethical Drug Manufacturers |
| Country: |
UNITED STATES |
| Employees: |
530 |
Business Description
ZymoGenetics, Inc.. The Company's principal activities are discovering and developing novel protein therapeutics that are based on their research and biological insights into key disease pathways. The Company develops and markets RECOTHROM Thrombin, topical (Recombinant), which is the first recombinant, plasma-free thrombin. Other product candidates span a wide array of clinical opportunities that include cancer, autoimmune and viral diseases. The Company intends to commercialize product candidates through internal development, collaborations with partners, and out-licensing of patents from its extensive patent portfolio.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
